Zollinger-Ellison syndrome. Case report

Introduction: The Zollinger-Ellison syndrome (ZES) is a pathology caused by a neuroendocrine tumor, usually located in the pancreas or the duodenum, which is characterized by elevated levels of gastrin, resulting in an excessive production of gastric acid. Case presentation: A 42-year-old female p...

Full description

Saved in:
Bibliographic Details
Main Authors: Juan Felipe Rivillas-Reyes, Juan Leonel Castro-Avendaño, Héctor Fabián Martínez-Muñoz
Format: Article
Language:English
Published: Universidad Nacional de Colombia 2019-01-01
Series:Case Reports
Subjects:
Online Access:https://revistas.unal.edu.co/index.php/care/article/view/71686
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846152078863368192
author Juan Felipe Rivillas-Reyes
Juan Leonel Castro-Avendaño
Héctor Fabián Martínez-Muñoz
author_facet Juan Felipe Rivillas-Reyes
Juan Leonel Castro-Avendaño
Héctor Fabián Martínez-Muñoz
author_sort Juan Felipe Rivillas-Reyes
collection DOAJ
description Introduction: The Zollinger-Ellison syndrome (ZES) is a pathology caused by a neuroendocrine tumor, usually located in the pancreas or the duodenum, which is characterized by elevated levels of gastrin, resulting in an excessive production of gastric acid. Case presentation: A 42-year-old female patient with a history of longstanding peptic ulcer disease, who consulted due to persistent epigastric pain, melena and signs of peritoneal irritation.  Perforated peptic ulcer was suspected, requiring emergency surgical intervention. Subsequently, a tumor lesion in the head of the pancreas was documented and managed with Whipple procedure. The pathology results reported a tumor suggestive of neuroendocrine neoplasm. Discussion: The Zollinger-Ellison syndrome occurs in 0.1 to 3 people per 1 000 000 inhabitants worldwide and is predominant in women between 20 and 50 years of age. It usually appears as a refractory acid-peptic disease or as a complication of gastric acid hypersecretion. Medical therapy is the standard management, being proton pump inhibitors (PPI) the most effective option. Surgery is recommended for sporadic ZES. Conclusions: ZES has a low incidence rate. It is rarely considered in the differential diagnosis of chronic epigastric pain and high clinical suspicion is required to achieve adequate management. This article is highly relevant as it presents a confirmed clinical case of ZES in Colombia, highlighting the importance of producing local scientific literature to improve the diagnosis and treatment of this pathology.
format Article
id doaj-art-c5babde21a3d4277896ca5d252fdf4fe
institution Kabale University
issn 2462-8522
language English
publishDate 2019-01-01
publisher Universidad Nacional de Colombia
record_format Article
series Case Reports
spelling doaj-art-c5babde21a3d4277896ca5d252fdf4fe2024-11-26T23:59:26ZengUniversidad Nacional de ColombiaCase Reports2462-85222019-01-015110.15446/cr.v5n1.7168650171Zollinger-Ellison syndrome. Case reportJuan Felipe Rivillas-Reyes0Juan Leonel Castro-Avendaño1Héctor Fabián Martínez-Muñoz2Universidad Nacional de Colombia - Sede Bogotá - Facultad de Medicina - Programa de MedicinaUniversidad Nacional de Colombia - Sede Bogotá - Facultad de Medicina - Programa de MedicinaUniversidad Nacional de Colombia - Sede Bogotá - Facultad de Medicina - Departamento de Cirugía Introduction: The Zollinger-Ellison syndrome (ZES) is a pathology caused by a neuroendocrine tumor, usually located in the pancreas or the duodenum, which is characterized by elevated levels of gastrin, resulting in an excessive production of gastric acid. Case presentation: A 42-year-old female patient with a history of longstanding peptic ulcer disease, who consulted due to persistent epigastric pain, melena and signs of peritoneal irritation.  Perforated peptic ulcer was suspected, requiring emergency surgical intervention. Subsequently, a tumor lesion in the head of the pancreas was documented and managed with Whipple procedure. The pathology results reported a tumor suggestive of neuroendocrine neoplasm. Discussion: The Zollinger-Ellison syndrome occurs in 0.1 to 3 people per 1 000 000 inhabitants worldwide and is predominant in women between 20 and 50 years of age. It usually appears as a refractory acid-peptic disease or as a complication of gastric acid hypersecretion. Medical therapy is the standard management, being proton pump inhibitors (PPI) the most effective option. Surgery is recommended for sporadic ZES. Conclusions: ZES has a low incidence rate. It is rarely considered in the differential diagnosis of chronic epigastric pain and high clinical suspicion is required to achieve adequate management. This article is highly relevant as it presents a confirmed clinical case of ZES in Colombia, highlighting the importance of producing local scientific literature to improve the diagnosis and treatment of this pathology. https://revistas.unal.edu.co/index.php/care/article/view/71686GastrinomaZollinger-Ellison SydromeMultiple Endocrine Neoplasia Type 1.
spellingShingle Juan Felipe Rivillas-Reyes
Juan Leonel Castro-Avendaño
Héctor Fabián Martínez-Muñoz
Zollinger-Ellison syndrome. Case report
Case Reports
Gastrinoma
Zollinger-Ellison Sydrome
Multiple Endocrine Neoplasia Type 1.
title Zollinger-Ellison syndrome. Case report
title_full Zollinger-Ellison syndrome. Case report
title_fullStr Zollinger-Ellison syndrome. Case report
title_full_unstemmed Zollinger-Ellison syndrome. Case report
title_short Zollinger-Ellison syndrome. Case report
title_sort zollinger ellison syndrome case report
topic Gastrinoma
Zollinger-Ellison Sydrome
Multiple Endocrine Neoplasia Type 1.
url https://revistas.unal.edu.co/index.php/care/article/view/71686
work_keys_str_mv AT juanfeliperivillasreyes zollingerellisonsyndromecasereport
AT juanleonelcastroavendano zollingerellisonsyndromecasereport
AT hectorfabianmartinezmunoz zollingerellisonsyndromecasereport